(Q43177625)

15 November 2017

title

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs (English)

1 reference

15 November 2017

1

1 reference

15 November 2017

4

1 reference

Jennifer McKimm-Breschkin

15 November 2017

object named as

Jennifer L McKimm-Breschkin

series ordinal

2

0 references

Naomi Komadina

series ordinal

5

object named as

Naomi Komadina

1 reference

15 November 2017

6

Alan W Hampson

1 reference

15 November 2017

Mandy McDonald

3

1 reference

15 November 2017

publication date

1 July 2004

1 reference

15 November 2017

1 reference

15 November 2017

volume

103

1 reference

15 November 2017

issue

1-2

1 reference

15 November 2017

page(s)

205-211

1 reference

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Influenza virus neuraminidase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Resistance of influenza viruses to neuraminidase inhibitors--a review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Neuraminidase inhibitors for the treatment and prevention of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Treatment of influenza with neuraminidase inhibitors: virological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Complete nucleotide sequence of the neuraminidase gene of influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Position statement: global neuraminidase inhibitor susceptibility network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2004.02.035

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2004.02.035

1 reference

15 November 2017

1 reference